Potent antifibrotic activity of mTOR inhibitors Sirolimus and Everolimus but not of Cyclosporine A and Tacrolimus in experimental liver fibrosis

2010 ◽  
Vol 48 (01) ◽  
Author(s):  
E Patsenker ◽  
M Ledermann ◽  
H Saegesser ◽  
V Schneider ◽  
F Stickel
Keyword(s):  
Liver Fibrosis ◽  
Cyclosporine A ◽  
Mtor Inhibitors ◽  
Experimental Liver

Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis

2011 ◽  
Vol 55 (2) ◽  
pp. 388-398 ◽  
Author(s):  
Eleonora Patsenker ◽  
Vreni Schneider ◽  
Monika Ledermann ◽  
Hans Saegesser ◽  
Christoph Dorn ◽  
...  
Keyword(s):  
Liver Fibrosis ◽  
Cyclosporine A ◽  
Mtor Inhibitors ◽  
Experimental Liver

scholarly journals Endothelial nitric oxide synthase is a critical factor in experimental liver fibrosis

2008 ◽  
Vol 89 (4) ◽  
pp. 241-250 ◽  
Author(s):  
Tung-Ming Leung ◽  
George L. Tipoe ◽  
Emily C. Liong ◽  
Thomas Y.H. Lau ◽  
Man-Lung Fung ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Nitric Oxide Synthase ◽  
Liver Fibrosis ◽  
Endothelial Nitric Oxide Synthase ◽  
Critical Factor ◽  
Oxide Synthase ◽  
Endothelial Nitric Oxide ◽  
Experimental Liver

Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis

2017 ◽  
Vol 266 ◽  
pp. 226-237 ◽  
Author(s):  
Nesrine S. El-Mezayen ◽  
Wessam F. El-Hadidy ◽  
Wessam M. El-Refaie ◽  
Th.I. Shalaby ◽  
Mahmoud M. Khattab ◽  
...  
Keyword(s):  
Liver Fibrosis ◽  
Hepatic Stellate Cell ◽  
Stellate Cell ◽  
Novel Strategy ◽  
Experimental Liver

scholarly journals Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice

2010 ◽  
Vol 120 (11) ◽  
pp. 4129-4140 ◽  
Author(s):  
Marie-Luise Berres ◽  
Rory R. Koenen ◽  
Anna Rueland ◽  
Mirko Moreno Zaldivar ◽  
Daniel Heinrichs ◽  
...  
Keyword(s):  
Liver Fibrosis ◽  
Experimental Liver
Sign in / Sign up

Export Citation Format

Share Document